ABCM Abcam
WatchlistAbcam News
Cell Surface Markers Market Size to Grow by USD 14.06 Billion From 2023-2028| Abbott Laboratories, Abcam Plc, Agilent Technologies Inc., and More Among the Key Companies In the Market - Technavio
The Cell Surface Markers Market size is expected to grow by USD 14.06 billion, accelerating at a CAGR of 8.25% during the forecast period, according...
Trending Stocks Today: Safe & Green Development Surges 122.44% Pre-Market
November 17th - US stocks trending pre-market: Gainers: $Safe & Green Development(SGD.US)$ soars 122.44% to $6.74 with a turnover of $21.82 million. $Li Auto(LI.US)$ up 3.83% to $40.36 with a turnover
Express News | Abcam Has Obtained All Clearances Required In Connection With Proposed Acquisition By Danaher For $24.00 Per Share In Cash
Global Metabolism Assays Markets 2023-2028 With Merck, Thermo Fisher, Abcam, and Agilent Technologies Dominating
DUBLIN, Nov. 15, 2023 /PRNewswire/ -- The "Global Metabolism Assays Market by Product (Instruments, Assays Kits), Technology (Colorimetry, Fluorimetry, Spectrometry), Application (Diagnostics (Diabet
Abcam Ticks Higher Amid Report of China Approval for Sale to Danaher
Express News | Abcam Shareholders Approve Proposed Acquisition By Danaher
Statement From Dr. Jonathan Milner on the Suspension of the "Vote AGAINST" Campaign
Statement from Dr. Jonathan Milner on the suspension of the "Vote AGAINST" campaign CAMBRIDGE, England, 1 November 2023 - Jonathan Milner, the founder and one of the largest investors in Abcam plc ("Abcam" or the
RBC Trims Price Target on Abcam to $24 From $25, Keeps Sector Perform Rating
RBC Trims Price Target on Abcam to $24 From $25, Keeps Sector Perform Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Abcam (ABCM), Viridian Therapeutics (VRDN) and Merck & Company (MRK)
Global ELISA Analyzers Market Report 2023-2028 With Competitive Analysis of Thermo Fisher Scientific, Abcam, Bio-Rad Labs, Merck, F. Hoffmann-La Roche, Danaher, BioTech, Agilent, QIAGEN, & PerkinElmer
The "ELISA Analyzers Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028F" report has been added to...
She Blinded Me With Science – ISS Makes Schoolboy Error on Abcam Deal
Abcam Holders Should Vote for Sale to Danaher, Proxy Adviser ISS Says
Jonathan Milner Releases Presentation to Abcam Plc Shareholders, Outlining Reasons to Reject Danaher's Bid and Strategic Vision for the Company
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company CAMBRIDGE, England, 16 October 2023 – Dr. Jonathan Milner, the founder
HBK Capital Becomes Biggest Abcam Investor, Set to Support Sale
Unusual Options Activity: THC, MDLZ and Others Attract Market Bets, THC V/OI Ratio Reaches 2000.0
EST Oct 12th Afternoon Delivery - In the last 2 hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
RBC Capital Reiterates Sector Perform on Abcam, Maintains $25 Price Target
RBC Capital analyst Alistair Campbell reiterates Abcam with a Sector Perform and maintains $25 price target.
Abcam (ABCM) Gets a Hold From RBC Capital
Abcam Sends Letter Seeking Shareholders' Approval of Danaher's Takeover Offer
Abcam (ABCM) said Thursday that it has sent a letter to shareholders recommending approval of Danaher Corporation's (DHR) proposal to acquire all of the outstanding shares of Abcam for $24 per share i
Global EV-Based Liquid Biopsy Market Research Report 2023-2032 Featuring Abcam, Bio-Techne, Horiba, Qiagen, Thermo Fisher Scientific, Malvern Panalytical, Lonza, Revvity, Takara Bio, & Norgen Biotek
DUBLIN, Oct. 5, 2023 /PRNewswire/ -- The "Global EV-Based Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Workflow, Sample Type, End User, Technology, Regional Analysis, and
Express News | Jonathan Milner, The Founder And One Of The Largest Investors In Abcam, Urges Shareholders To Reject The Danaher Acquisition In An Open Letter